Results 151 to 160 of about 112,378 (256)

Neurotransmitter signaling in white matter [PDF]

, 2014
Butt, Arthur M., Fern, Robert F., Matute, Carlos   +2 more
core   +1 more source

Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Chemical Reviews, 2016
C. Lindsley, K. Emmitte, C. Hopkins, T. Bridges, K. J. Gregory, C. Niswender, C. Niswender, P. J. Conn, P. J. Conn   +8 more
semanticscholar   +1 more source

Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors. [PDF]

Cells, 2022
Mazzitelli M, Presto P, Antenucci N, Meltan S, Neugebauer V.   +4 more
europepmc   +1 more source

Mechanism of Assembly and Cooperativity of Homomeric and Heteromeric Metabotropic Glutamate Receptors

Neuron, 2016
Joshua Levitz, Chris H. Habrian, S. Bharill, Zhu Fu, Reza Vafabakhsh, E. Isacoff   +5 more
semanticscholar   +1 more source

Phosphorylation and regulation of group II metabotropic glutamate receptors (mGlu2/3) in neurons. [PDF]

Front Cell Dev Biol, 2022
Mao LM, Mathur N, Mahmood T, Rajan S, Chu XP, Wang JQ.   +5 more
europepmc   +1 more source

Metabotropic Glutamate Receptors at Ribbon Synapses in the Retina and Cochlea. [PDF]

Cells, 2022
Klotz-Weigand L, Enz R.
europepmc   +1 more source

Modulation of Metabotropic Glutamate Receptors as a Strategy to Improve the Efficacy and Safety of Ketamine as an Antidepressant. [PDF]

Cells
Pałucha-Poniewiera A.
europepmc   +1 more source

Coevolutionary signals in metabotropic glutamate receptors capture residue contacts and long-range functional interactions. [PDF]

J Biol Chem, 2023
Huh E, Agosto MA, Wensel TG, Lichtarge O.   +3 more
europepmc   +1 more source

Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Alborghetti M, Ceccherelli A, Caridi M, Nicoletti F, Battaglia G, Bruno V.   +5 more
europepmc   +1 more source

Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease. [PDF]

Pharmacol Rev, 2022
Luessen DJ, Conn PJ.
europepmc   +1 more source